• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review.镰状细胞病首次发病的不同年龄:病例报告与综述
Case Rep Med. 2021 Feb 8;2021:8895020. doi: 10.1155/2021/8895020. eCollection 2021.
2
Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.镰状细胞病、其他血红蛋白病和葡萄糖-6-磷酸脱氢酶缺乏症新生儿筛查的区域经验。
Ann Saudi Med. 2003 Nov-Dec;23(6):354-7. doi: 10.5144/0256-4947.2003.354.
3
Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.镰状细胞病患者从出生到5岁的参考值及血液学变化。镰状细胞病合作研究。
Arch Pediatr Adolesc Med. 1994 Aug;148(8):796-804. doi: 10.1001/archpedi.1994.02170080026005.
4
Genetic Blood Disorders Survey in the Sultanate of Oman.阿曼苏丹国的遗传性血液疾病调查。
J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20.
5
[Neonatal screening of hemoglobinopathies and G6PD deficiency in Catalonia (Spain). Molecular study of sickle cell disease associated with alpha thalassemia and G6PD deficiency].[西班牙加泰罗尼亚地区血红蛋白病和葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症的新生儿筛查。与α地中海贫血和G6PD缺乏症相关的镰状细胞病的分子研究]
Med Clin (Barc). 2007 Jun 30;129(5):161-4. doi: 10.1157/13107791.
6
Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.小型综述:镰状细胞病异质性和严重程度的遗传基础
Exp Biol Med (Maywood). 2016 Apr;241(7):689-96. doi: 10.1177/1535370216636726. Epub 2016 Mar 1.
7
Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.镰状细胞贫血与α地中海贫血并发:对贫血严重程度的影响。
N Engl J Med. 1982 Feb 4;306(5):270-4. doi: 10.1056/NEJM198202043060504.
8
Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study.葡萄糖-6-磷酸脱氢酶缺乏症对婴儿和幼儿期镰状细胞贫血表达的影响:一项前瞻性研究。
Br J Haematol. 2013 Dec;163(5):646-54. doi: 10.1111/bjh.12590. Epub 2013 Oct 10.
9
Genetic Background of the Sickle Cell Disease Pediatric Population of Dakar, Senegal, and Characterization of a Novel Frameshift β-Thalassemia Mutation [HBB: c.265_266del; p.Leu89Glufs*2].塞内加尔达喀尔镰状细胞病儿科人群的遗传背景及一种新型移码β地中海贫血突变[HBB:c.265_266del;p.Leu89Glufs*2]的特征分析
Hemoglobin. 2017 Mar;41(2):89-95. doi: 10.1080/03630269.2017.1339610. Epub 2017 Jul 3.
10
The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease.葡萄糖-6-磷酸脱氢酶缺乏症对镰状细胞病患者的临床影响。
Curr Opin Hematol. 2018 Nov;25(6):494-499. doi: 10.1097/MOH.0000000000000455.

引用本文的文献

1
The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape.镰状细胞病的表型:在意大利环境中帮助识别未确诊患者的策略。
Ital J Pediatr. 2025 May 28;51(1):157. doi: 10.1186/s13052-025-01992-y.
2
Non - Invasive, smartphone image-based screening for sickle cell disease at the point-of-need.基于智能手机图像的非侵入性即时镰状细胞病筛查。
Heliyon. 2025 Jan 10;11(2):e41830. doi: 10.1016/j.heliyon.2025.e41830. eCollection 2025 Jan 30.
3
Late diagnosis of sickle cell disease in adults still a challenge in developing countries: a case report.成人镰状细胞病的迟诊在发展中国家仍是一个挑战:病例报告。
J Med Case Rep. 2024 Nov 21;18(1):556. doi: 10.1186/s13256-024-04858-9.
4
Importance of Hemoglobin SC (HbSC) Screening: Diagnosis of Sickle Cell HbSC Disease Following Hemolytic Crisis and Pulmonary Embolism Due to Peripherally Inserted Central Catheter (PICC Line) Thrombosis.血红蛋白SC(HbSC)筛查的重要性:在溶血性危机以及因经外周静脉穿刺中心静脉导管(PICC)血栓形成导致的肺栓塞后诊断镰状细胞HbSC病。
Cureus. 2024 Aug 11;16(8):e66628. doi: 10.7759/cureus.66628. eCollection 2024 Aug.
5
Unraveling the Complexity of Vaso-Occlusive Crises in Sickle Cell Disease: Insights from a Resource-Limited Setting.揭示镰状细胞病血管闭塞性危象的复杂性:来自资源有限环境的见解
J Clin Med. 2024 Apr 25;13(9):2528. doi: 10.3390/jcm13092528.

本文引用的文献

1
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort.首次疼痛危象年龄及相关并发症在 CASiRe 国际镰状细胞病队列中的表现。
Blood Cells Mol Dis. 2021 May;88:102531. doi: 10.1016/j.bcmd.2020.102531. Epub 2021 Jan 2.
2
Caring for Africa's sickle cell children: will we rise to the challenge?关爱非洲镰状细胞病患儿:我们能迎接挑战吗?
BMC Med. 2020 Apr 28;18(1):92. doi: 10.1186/s12916-020-01557-2.
3
Sickle cell disease in Germany: Results from a national registry.德国镰状细胞病:国家登记处的结果。
Pediatr Blood Cancer. 2020 Apr;67(4):e28130. doi: 10.1002/pbc.28130. Epub 2019 Dec 22.
4
Sickle cell disease: current treatment and emerging therapies.镰状细胞病:当前的治疗方法与新兴疗法
Am J Manag Care. 2019 Nov;25(18 Suppl):S335-S343.
5
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study.来自多国家DOVE研究的镰状细胞贫血患儿的表型和治疗的地理差异。
J Clin Med. 2019 Nov 17;8(11):2009. doi: 10.3390/jcm8112009.
6
Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.并非所有的红细胞都镰变:网织红细胞对镰状细胞贫血疾病病理的贡献。
Blood Rev. 2020 Mar;40:100637. doi: 10.1016/j.blre.2019.100637. Epub 2019 Nov 5.
7
Epidemiological, clinical, and severity characterization of sickle cell disease in a population from the Brazilian Amazon.巴西亚马逊地区人群镰状细胞病的流行病学、临床及严重程度特征
Hematol Oncol Stem Cell Ther. 2019 Dec;12(4):204-210. doi: 10.1016/j.hemonc.2019.04.002. Epub 2019 May 28.
8
Sickle cell disease: Clinical presentation and management of a global health challenge.镰状细胞病:全球健康挑战的临床表现和管理。
Blood Rev. 2019 Sep;37:100580. doi: 10.1016/j.blre.2019.05.004. Epub 2019 May 20.
9
Comorbidity of Glucose-6-Phosphate Dehydrogenase Deficiency and Sickle Cell Disease Exert Significant Effect on RBC Indices.葡萄糖-6-磷酸脱氢酶缺乏症与镰状细胞病的合并症对红细胞指数有显著影响。
Anemia. 2019 Mar 19;2019:3179173. doi: 10.1155/2019/3179173. eCollection 2019.
10
Community perceptions of paediatric severe anaemia in Uganda.乌干达社区对儿科严重贫血的认知。
PLoS One. 2019 Jan 3;14(1):e0209476. doi: 10.1371/journal.pone.0209476. eCollection 2019.

镰状细胞病首次发病的不同年龄:病例报告与综述

Varied Age of First Presentation of Sickle Cell Disease: Case Presentations and Review.

作者信息

Claeys Alexis, Van Steijn Susanne, Van Kesteren Lydia, Damen Elizabet, Van Den Akker Machiel

机构信息

Pediatric Department, ZNA Paola Children's Hospital, Antwerp, Belgium.

Pediatric Department, UZ Gent, Gent, Belgium.

出版信息

Case Rep Med. 2021 Feb 8;2021:8895020. doi: 10.1155/2021/8895020. eCollection 2021.

DOI:10.1155/2021/8895020
PMID:33628264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884135/
Abstract

Sickle cell disease is a multisystem condition characterized by hemolytic anemia and vasoocclusion. Not only are the symptoms of the first presentation but also the ages of presentation are very variable. Following three case reports, different causes of possible late presentation are discussed. Many factors are responsible for the age at which sickle cell disease is diagnosed: doctor's delay (unfamiliarity with the disease), patient's delay (education and financial position of the parents, cultural factors), high- versus low-resource country (availability of newborn screening), fetal hemoglobin, reticulocyte count, and genetic modulators, such as SCD genotype, alpha-thalassemia, fetal hemoglobin concentration, and G6PD deficiency. The individual course of sickle cell disease depends on (epi) genetic and environmental properties and the underlying interactions. In further studies, the role of each factor should be evaluated more deeply, and its use as a marker of disease severity or activity should be assessed.

摘要

镰状细胞病是一种以溶血性贫血和血管阻塞为特征的多系统疾病。首次出现症状的表现以及出现症状的年龄都非常多变。在三个病例报告之后,讨论了可能出现延迟表现的不同原因。许多因素导致镰状细胞病被诊断的年龄:医生的延误(对该疾病不熟悉)、患者的延误(父母的教育程度和经济状况、文化因素)、高资源国家与低资源国家(新生儿筛查的可及性)、胎儿血红蛋白、网织红细胞计数以及遗传调节因子,如镰状细胞病基因型、α地中海贫血、胎儿血红蛋白浓度和葡萄糖-6-磷酸脱氢酶缺乏症。镰状细胞病的个体病程取决于(表观)遗传和环境特性以及潜在的相互作用。在进一步的研究中,应更深入地评估每个因素的作用,并评估其作为疾病严重程度或活动标志物的用途。